M&G Plc

Institutional investor · Portfolio as of Q2 2026

Top Holdings374 positions

Checking export access…
Activity:
AMCR

Amcor plc

27.7M$1.2B5.9%$38.93+20.63%
2 qtrssince 2026-Q1
Increased
68
MSFT

Microsoft Corporation

2.4M$910.2M4.5%$403.07+29.25%
10 qtrssince 2024-Q1
Decreased
0
AZN

AstraZeneca PLC

4.5M$838.2M4.2%$196.75-6.54%
2 qtrssince 2026-Q1
Increased
62
AVGO

Broadcom Inc.

1.6M$607.2M3.0%$288.44+15.15%
10 qtrssince 2024-Q1
Increased
75
MEOH

Methanex Corporation

12.3M$567.9M2.8%$42.79+63.32%
10 qtrssince 2024-Q1
Decreased
0
META

Meta Platforms, Inc.

869,789$489.7M2.4%$522.44+18.87%
10 qtrssince 2024-Q1
Decreased
0
GOOGL

Alphabet Inc.

1.3M$474.5M2.4%$159.30+75.79%
10 qtrssince 2024-Q1
Decreased
0
VFC

V.F. Corporation

25.8M$439.2M2.2%$14.64+36.92%
10 qtrssince 2024-Q1
Increased
53
NEE

NextEra Energy, Inc.

4.1M$361.4M1.8%$62.08+35.84%
10 qtrssince 2024-Q1
Increased
50
WFC

Wells Fargo & Company

3.9M$322.1M1.6%$79.05+8.19%
10 qtrssince 2024-Q1
Decreased
0
UNH

UnitedHealth Group Incorporated

745,287$310M1.5%$399.62+1.21%
10 qtrssince 2024-Q1
Decreased
0
BMY

Bristol-Myers Squibb Company

5.3M$306.9M1.5%$45.10+36.82%
10 qtrssince 2024-Q1
Decreased
0
MDT

Medtronic plc.

3.9M$304.3M1.5%$81.37+21.52%
10 qtrssince 2024-Q1
Increased
56
V

Visa Inc.

843,989$289.5M1.4%$285.93+47.03%
10 qtrssince 2024-Q1
Decreased
0
AAPL

Apple Inc.

993,209$287M1.4%$208.74+59.00%
10 qtrssince 2024-Q1
Decreased
0
JCI

Johnson Controls International plc

2M$285.8M1.4%$80.57+86.06%
10 qtrssince 2024-Q1
Decreased
0
NVDA

NVIDIA Corporation

1.4M$281.2M1.4%$151.91+36.06%
10 qtrssince 2024-Q1
Decreased
0
UBS

UBS Group AG Registered

5.3M$262.7M1.3%$32.25+48.84%
10 qtrssince 2024-Q1
Increased
52
RSG

Republic Services, Inc.

1.2M$262.3M1.3%$215.76+12.57%
10 qtrssince 2024-Q1
Increased
52
MICC

The Magnum Ice Cream Company N.V.

15.2M$261.2M1.3%$15.59+24.39%
3 qtrssince 2025-Q4
Increased
52
$20.1B
AUM
374
Positions
Q2 2026
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$20,902,129,65329.019885357%
2025-Q2$18,153,475,542-13.1501151157%
2025-Q3$18,807,137,5043.60075380876%
2025-Q4$19,466,970,1473.50841611521%
2026-Q1$19,360,270,594-0.548105597298%
2026-Q2$20,121,389,1673.93134263958%
Activity profile
$ moved · Q2'26
New10%Increased40%Decreased44%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q7%1-4Q19%1-2Y16%2Y+58%

M&G Plc manages $20.1B across 374 positions as of Q2 2026. Top holdings: AMCR (5.9%), MSFT (4.5%), AZN (4.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.

Q2 2026 Summary

Active quarter - 32 new positions, 39 exits, 129 increased. Top move: AVGO (INCREASED, conviction 75). Portfolio: $20.1B across 374 positions.

Top holdings by portfolio weight

Total AUM$20B
AMCR5.93%
MSFT4.52%
AZN4.17%
AVGO3.02%
MEOH2.82%
META2.43%
GOOGL2.36%
VFC2.18%
NEE1.80%
WFC1.60%
Other1.54%

Portfolio allocation by GICS sector

Sectors11
Technology21.66%
Healthcare17.65%
Consumer Cyclical16.55%
Financial Services11.96%
Industrials6.48%
Communication Services6.28%
Basic Materials4.99%
Utilities4.57%
Energy3.85%
Real Estate2.89%
Other3.12%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L57
Conviction54
Concentration46
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BSXBSXBoston Scientific Corporation
Q4 2024 → Q2 2026+633,989 shares+$26.6M
7Q
INTUINTUIntuit Inc.
Q4 2024 → Q2 2026+392,912 shares+$87.3M
7Q
VFCVFCV.F. Corporation
Q4 2024 → Q2 2026+10.9M shares+$139.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used